Home/Filings/4/0001437749-24-030616
4//SEC Filing

Simpson Jennifer K. 4

Accession 0001437749-24-030616

CIK 0001029125other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:25 PM ET

Size

5.4 KB

Accession

0001437749-24-030616

Insider Transaction Report

Form 4
Period: 2024-10-01
Simpson Jennifer K.
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2024-10-01+72,80072,800 total
    Exercise: $0.39Exp: 2034-10-01Common Stock (72,800 underlying)
Footnotes (1)
  • [F1]The option fully vests on October 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Issuer

Panbela Therapeutics, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001545253

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:25 PM ET
Size
5.4 KB